Total Funding
36
78
Total FundingSeries A raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
45778
Pdx Pharmaceuticals develop novel combination and immunotherapies to treat cancer.
- Wassana Yantasee: Founder & President/CEO
Worapol Ngamcherdtrakul: Chief Operating Officer & Principal Scientist
About the Company
Pdx Pharmaceuticals is a biopharmaceutical company. They provide common biological pathways to achieve synergistic clinical benefit. Their therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production.
Women Founded
Women Led
